| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 22, 2024 4:30 P.M. |
| Form: | S-3 | |||||
|
Attachments
Disclaimer
Enveric Biosciences Inc. published this content on 22 January 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 January 2024 11:05:21 UTC.
